| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |